Doktor Bilgileri

Nimesh P Nagarsheth

Onkoloji
United States, New York

Dr. Nimesh P. Nagarsheth is an internationally-recognized Gynecologic Oncologist with a priamry practice at Englewood Health in Englewood, New Jersey. In addition to serving on faculty as a Clinical Professor at Mount Sinai, he also serves as Director of Gynecologic Oncology and Director of Robotic Surgery at Englewood Health. In his practice, Dr. Nagarsheth provides the full range of surgical and medical gynecologic oncology care, and is recognized as the world’s expert in performing Bloodless Surgery (transfusion-free surgery) in Gynecology and Gynecologic Oncology. In addition, his work and publications on humanistic care and the intersection of music and medicine have also gained him international recognition.

 

Dr. Nagarsheth graduated with honors (Alpha Omega Alpha) from the Mount Sinai School of Medicine. He completed his residency training in Obstetrics and Gynecology at Duke University Medical Center, and completed his fellowship in Gynecologic Oncology at Mount Sinai. Throughout his training and career, Dr. Nagarsheth has won numerous teaching, research, and clinical awards including receiving the prestigious Public Service Award by the Foundation For Women's Cancer in 2018/2019. During his training, Dr. Nagarsheth also conducted cutting-edge research at New York University Medical Center and Memorial Sloan-Kettering Cancer Center in New York.

 

Dr. Nagarsheth has performed extensive research on the mechanisms of cancer prevention, including the hormonal manipulation of apoptosis. He is a lead author on a landmark study that provides the most convincing evidence yet for a novel theory of how birth control pills help prevent ovarian cancer. He has continued his research at Mount Sinai evaluating the role of hormonal effects on gynecologic organs, and has developed an extensive research background in blood management in the field of Gynecologic Oncology. He speaks frequently at national meetings and serves as a principal investigator for several national clinical trials.